Can a GLP-1 Pill Revive Novo Nordisk? episode artwork

EPISODE · Jan 7, 2026 · 30 MIN

Can a GLP-1 Pill Revive Novo Nordisk?

from Prof G Markets · host Vox Media Podcast Network

Ed Elson speaks with Alex Heath, host of the ACCESS Podcast, about why Nvidia is dominating the news out of the CES conference. Then Jared Holz, Healthcare Equity Strategist at Mizuho, joins the show to discuss what Novo Nordisk’s new Wegovy pill means for the healthcare industry.  Check out our latest Prof G Markets newsletter Follow Prof G Markets on Instagram Follow Ed on Instagram, X and Substack Follow Scott on Instagram Learn more about your ad choices. Visit podcastchoices.com/adchoices

Episode metadata supplied by the publisher feed · Published Jan 7, 2026

Embed this episode

NOW PLAYING

Can a GLP-1 Pill Revive Novo Nordisk?

0:00 30:53

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Prof G Markets?

This episode is 30 minutes long.

When was this Prof G Markets episode published?

This episode was published on January 7, 2026.

Can I download this Prof G Markets episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!